ISSN: 1539-1604

Journal Home

Journal Guideline

Pharmaceutical Statistics Q1 Unclaimed

John Wiley and Sons Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pharmaceutical Statistics is a journal indexed in SJR in Pharmacology and Statistics and Probability with an H index of 46. It has a price of 3000 €. It has an SJR impact factor of 1,074 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,074.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pharmacology (Q1) Pharmacology (medical) (Q1) Pharmacology (medical) (Q1) Statistics and Probability (Q1)

Price

3000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,074

SJR Impact factor

46

H Index

80

Total Docs (Last Year)

266

Total Docs (3 years)

2401

Total Refs

460

Total Cites (3 years)

252

Citable Docs (3 years)

1.77

Cites/Doc (2 years)

30.01

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Journal for ImmunoTherapy of Cancer Q1

Compare this journals

Aims and Scope

Best articles by citations

Estimation of group means in generalized linear mixed models

Estimation of group means when adjusting for covariates in generalized linear models

Statistics at Square One, Tenth Edition. Swinscow TDV, Campbell MJ (2001)ISBN 0727915525; 158 pages; BMJ Books, London;

Statistics at Square Two: Understanding Modern Statistical Applications in Medicine. Campbell MJ (2001)ISBN 0729713948; 133 pages; BMJ Books, London;

Top tip: ways of dealing with analytical constraints in pharmaceutical technology

A method for obtaining randomized block designs in preclinical studies with multiple quantitative blocking variables

Editorial

Statistics in Clinical Practice (Second Edition)Coggon D (2003)ISBN 0727916092; 120 pages; ¬£14.95 (¬£11.21as e-book)BMJ Books; http://www.bmjbookshop.com/shop/product_display.asp?AssocID=2&productid=0727916092

Introduction

Case study in the Bayesian analysis of a cost-effectiveness trial in the evaluation of health care technologies: Depression

Bayesian Statistical Modelling Congdon P (2001)ISBN 0471496006; 556 pages; Wiley;Applied Bayesian Modelling Congdon P (2003)ISBN 0471486957; 478 pages; Wiley;

Common threads between sample size recalculation and group sequential procedures

SHOW MORE ARTICLES

Editorial

Modelling Binary Data (Second Edition) Collett D (2003)ISBN 1584883243; 387 pages; CRC Press;

Tobit regression for modeling mean survival time using data subject to multiple sources of censoring

Assessing departure from dose linearity under a repeated measures incomplete block design

Literature Review June-September 2004

Action following the discovery of a global association between the whole genome and adverse event risk in a clinical drug-development programme

The ABC of non-inferiority margin setting from indirect comparisons

Literature review September-December 2003

The ABC of pharmaceutical trial design: some basic principles

Literature review, June 2003-September 2003

Some recent books about six sigma

A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among components